Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis
Open Access
- 9 June 2025
- journal article
- Published by Aboutscience Srl in Journal of Circulating Biomarkers
- Vol. 14 (1) , 5-11
Abstract
Background: Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, and it significantlyincreases the risk of cardiovascular disease and death. The evaluation of cardiovascular risk (CVR) is crucial inthese patients, but it may be underestimated using the current criteria, as they do not include nontraditionalCVR factors. Soluble ST-2, which is the circulating form of the IL-33 receptor, has been identified as a biomarkerfor cardiovascular and rheumatic diseases. In this study, we examined the role of sST-2 in assessing CVR in RA.Methods: Monocentric, retrospective, observational trial. Inclusion of RA patients on variable DMARD therapy.Analysis of RA disease using established scores (DAS 28, VAS, HFQ), clinical findings (number of swollen and painfuljoints), and laboratory investigation. Documentation of numerous CVR variables. Quantification of solublesST-2 by ELISA.Results: In total, 129 individuals were included. Soluble sST-2 did neither correlate nor was associated with anyvariable of RA disease activity. In contrast, significant associations were identified between sST-2 and a numberof established CVR markers.Conclusions: The data indicates a novel role for sST-2 in CVR prediction in RA.Keywords
This publication has 34 references indexed in Scilit:
- NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve SafetyJournal of Managed Care Pharmacy, 2013
- Lipid and Lipoprotein Levels and Trend in Rheumatoid Arthritis Compared to the General PopulationArthritis Care & Research, 2013
- ACR/EULAR 2010 rheumatoid arthritis classification criteriaRheumatology, 2012
- Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney DiseaseJournal of Clinical Immunology, 2011
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseAnnals of the Rheumatic Diseases, 2011
- Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid ArthritisJournal of Korean Medical Science, 2011
- Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?Angiology, 2010
- Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional studyClinical Rheumatology, 2010
- Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007Arthritis & Rheumatism, 2010
- Vergleichende Evaluation einer deutschen Version des Health Assessment Questionnaires (HAQ) und des Funktionsfragebogens Hannover (FFbH) (Comparative evaluation of a German version of the Health Assessment Questionnaire (HAQ) and the Hannover Functional Ability Questionnaire (HFAQ))Zeitschrift für Rheumatologie, 1997